![](https://webarchive.library.unt.edu/eot2008/20090514041943im_/http://www.cancer.gov/images/spacer.gif) |
|
(PROH-myoon)
![](https://webarchive.library.unt.edu/eot2008/20090514041943im_/http://www.cancer.gov/images/spacer.gif)
| A substance that is being studied in the treatment of some types of cancer. It belongs to the family of drugs called biological response modifiers. Also called CpG 7909 and PF-3512676. |
Previous Definitions: | proliferating, proliferative index, prolymphocytic leukemia, Promacta, promegapoietin | Next Definitions: | promyelocytic leukemia, prophylactic, prophylactic cranial irradiation, prophylactic mastectomy, prophylactic oophorectomy |
|
![](https://webarchive.library.unt.edu/eot2008/20090514041943im_/http://www.cancer.gov/images/spacer.gif) |